Latest debt-to-equity ratio
Summit Therapeutics Debt-to-equity ratio
Direct answer
Summit Therapeutics's debt-to-equity ratio is 3.24%.
The verified market snapshot reports 3.24%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 22, 2026.
Get free Summit Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 3.24%
Explore related company data
View Summit Therapeutics's market capitalizationView Summit Therapeutics's price-to-book ratioView Summit Therapeutics's return on equityView Summit Therapeutics's dividend yieldView Summit Therapeutics's 52-week price rangeView Summit Therapeutics's profit marginView all Summit Therapeutics key metricsReturn to Summit Therapeutics profile